(Q45396658)

14 December 2017

title

A cancer terminator virus eradicates both primary and distant human melanomas (English)

1 reference

eradication of infectious diseases

14 December 2017

main subject

1 reference

6

D T Curiel

1 reference

14 December 2017

D Sarkar

1

1 reference

14 December 2017

Z-Z Su

2

1 reference

14 December 2017

E-S Park

3

1 reference

14 December 2017

N Vozhilla

4

1 reference

14 December 2017

P Dent

5

1 reference

14 December 2017

P B Fisher

7

1 reference

14 December 2017

publication date

7 March 2008

1 reference

14 December 2017

1 reference

14 December 2017

volume

15

1 reference

14 December 2017

issue

5

1 reference

14 December 2017

page(s)

293-302

1 reference

Human melanoma: development and progression

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Interleukin-10 and related cytokines and receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

The melanoma differentiation associated gene mda-7 suppresses cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

The cancer growth suppressing gene mda-7 induces apoptosis selectively in human melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

mda-7 (IL-24) Mediates selective apoptosis in human melanoma cells by inducing the coordinated overexpression of the GADD family of genes by means of p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Melanoma differentiation associated gene-7/interleukin-24 (mda-7/IL-24): novel gene therapeutic for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Is mda-7/IL-24 a "magic bullet" for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

mda-7/IL-24: multifunctional cancer-specific apoptosis-inducing cytokine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

mda-7/IL-24: exploiting cancer's Achilles' heel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Melanoma differentiation associated gene-7 (mda-7)/IL-24: a 'magic bullet' for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Dual cancer-specific targeting strategy cures primary and distant breast carcinomas in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Melanoma differentiation associated gene-7, mda-7/IL-24, selectively induces growth suppression, apoptosis and radiosensitization in malignant gliomas in a p53-independent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Unique aspects of mda-7/IL-24 antitumor bystander activity: establishing a role for secretion of MDA-7/IL-24 protein by normal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Current strategies in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Cancer gene therapy by adenovirus-mediated gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Restoring apoptosis as a strategy for cancer gene therapy: focus on p53 and mda-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Replicative adenoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Conditional gene targeting for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Engineering regulatory elements for conditionally-replicative adeno-viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Targeting gene expression selectively in cancer cells by using the progression-elevated gene-3 promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Targeted virus replication plus immunotherapy eradicates primary and distant pancreatic tumors in nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Eradication of therapy-resistant human prostate tumors using a cancer terminator virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Subtraction hybridization identifies a transformation progression-associated gene PEG-3 with sequence homology to a growth arrest and DNA damage-inducible gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

PEG-3, a nontransforming cancer progression gene, is a positive regulator of cancer aggressiveness and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Cooperation between AP1 and PEA3 sites within the progression elevated gene-3 (PEG-3) promoter regulate basal and differential expression of PEG-3 during progression of the oncogenic phenotype in transformed rat embryo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

PEA3 sites within the progression elevated gene-3 (PEG-3) promoter and mitogen-activated protein kinase contribute to differential PEG-3 expression in Ha-ras and v-raf oncogene transformed rat embryo cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Unique conditionally replication competent bipartite adenoviruses-cancer terminator viruses (CTV): efficacious reagents for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Selectively replicating adenoviruses targeting deregulated E2F activity are potent, systemic antitumor agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Telomerase-dependent oncolytic adenovirus for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Melanoma differentiation-associated gene-7 (mda-7)/interleukin (IL)-24 induces anticancer immunity in a syngeneic murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

Syrian hamster as a permissive immunocompetent animal model for the study of oncolytic adenovirus vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

21 January 2018

Cancer statistics, 2007

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Issues in the epidemiology of melanoma

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Malignant melanoma: prevention, early detection, and treatment in the 21st century

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Mda-7, a novel melanoma differentiation associated gene with promise for cancer gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Clinical and local biological effects of an intratumoral injection of mda-7 (IL24; INGN 241) in patients with advanced carcinoma: a phase I study

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2008.14

7 January 2021

Identifiers

DOI

10.1038/CGT.2008.14

1 reference

Dimensions Publication ID

14 December 2017

1049654143

0 references

1 reference